SMYD3 promotes colon adenocarcinoma (COAD) progression by mediating cell proliferation and apoptosis

Colon adenocarcinoma (COAD) is a type of common malignant tumor originating in the digestive tract. Recently, targeted therapy has had significant effects on the treatment of COAD. However, more effective molecular targets need to be developed. SET and MYND domain-containing protein 3 (SMYD3) is a t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Fu-Ren, Wei, Zhi-Bin, Yan, Rui-Zhen, Guo, Qiu-Hong, Liu, Bing, Zhang, Jing-Hui, Li, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472017/
https://www.ncbi.nlm.nih.gov/pubmed/32934676
http://dx.doi.org/10.3892/etm.2020.9139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472017/
https://www.ncbi.nlm.nih.gov/pubmed/32934676
http://dx.doi.org/10.3892/etm.2020.9139

Ejemplares similares